Rectiv

Rectiv is a brand name of nitroglycerin, approved by the FDA in the following formulation(s):

RECTIV (nitroglycerin - ointment; intra-anal)

• 
  Manufacturer: APTALIS PHARMA
  
  Approval date: June 21, 2011
  
  Strength(s): 0.4% ^[RLD]

Has a generic version of Rectiv been approved?

No. There is currently no therapeutically equivalent version of Rectiv available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rectiv. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Nitric oxide donor composition and method for treatment of anal disorders
  Patent 7,189,761
  Issued: March 13, 2007
  Inventor(s): Gorfine; Stephen R.
  A pharmaceutical composition contains a nitric oxide donor and advantageously an optional corticosteroid and/or topical anesthetic. The composition is useful in a method for treating anal disorders such as anal fissure, anal ulcer, hemorrhoidal disease, levator spasm, and so forth, by topical application to or proximate the affected area.
  
  Patent expiration dates:
  
  
  • May 27, 2014
    
    ✓ 
    Patent use: RECTIV IS A NITRATE VASODILATOR INDICATED FOR THE TREATMENT OF MODERATE TO SEVERE PAIN ASSOCIATED WITH CHRONIC ANAL FISSURE
    ✓ 
    Drug product
  
  

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • June 21, 2014 - NEW PRODUCT
  
  

See also...

• Rectiv Consumer Information (Drugs.com)
• Nitroglycerin Consumer Information (Wolters Kluwer)
• Nitroglycerin Aerosol Consumer Information (Wolters Kluwer)
• Nitroglycerin Controlled-Release Capsules Consumer Information (Wolters Kluwer)
• Nitroglycerin Ointment Consumer Information (Wolters Kluwer)
• Nitroglycerin Patch Consumer Information (Wolters Kluwer)
• Nitroglycerin Spray Consumer Information (Wolters Kluwer)
• Nitroglycerin Tablets Consumer Information (Wolters Kluwer)
• Nitroglycerin oral/sublingual Consumer Information (Cerner Multum)
• Nitroglycerin topical Consumer Information (Cerner Multum)
• Nitroglycerin transdermal Consumer Information (Cerner Multum)
• Gen-Nitro Advanced Consumer Information (Micromedex)
• Nitrotab Advanced Consumer Information (Micromedex)
• Trinipatch 0.2 Advanced Consumer Information (Micromedex)
• Trinipatch 0.4 Advanced Consumer Information (Micromedex)
• Trinipatch 0.6 Advanced Consumer Information (Micromedex)
• Nitroglycerin Intravenous Advanced Consumer Information (Micromedex)
• Nitroglycerin Oral, Sublingual Advanced Consumer Information (Micromedex)
• Nitroglycerin Transdermal Advanced Consumer Information (Micromedex)
• Nitroglycerin AHFS DI Monographs (ASHP)